Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ.-Y. Douillard, R. Sidhu, J Cassidy et al.|Annals of Oncology|2014Cited by 603
Histone deacetylase 3 facilitates TNFα-mediated NF-κB activation through suppressing CTSB induced RIP1 degradation and is required for host defense against bacterial infectionLiping Yang, Feng Xu|Cell & Bioscience|2022Cited by 17